Hematology Frontier

The 2025 European Hematology Association (EHA) Annual Meeting was held in a hybrid format, both online and in-person, gathering top experts and scholars from the global hematology community. The conference focused on the deep integration of cutting-edge technology and clinical practice, with the application of Artificial Intelligence (AI) being one of the core topics. Professor Jakob Nikolas Kather from the Technische Universität Dresden, Germany, was invited to deliver a keynote speech titled "Artificial Intelligence in Hematology: Opportunities, Pitfalls, and How to Bring It into Clinical Practice." He systematically described the revolutionary changes in AI technology from its early explorations to the current era of large models. He particularly highlighted his team's pioneering research on empowering Tumor Board decision-making with AI Agents, charting a course for the future development of AI in hematologic oncology.

The 2025 European Hematology Association (EHA) Annual Meeting was recently held, bringing together top global experts in the field of hematologic malignancies to discuss the latest research findings and future directions. In the highly anticipated "Late-Breaking Abstract" session, Professor John Mascarenhas from the Icahn School of Medicine at Mount Sinai presented clinical study data on INCA33989, a novel, first-in-class monoclonal antibody specific to mutant calreticulin (CALR). The study results showed that INCA33989 demonstrated excellent safety and revolutionary therapeutic potential in previously treated patients with Essential Thrombocythemia (ET), with the potential to change the current treatment landscape

Editor's Note: With advancements in medicine, allogeneic hematopoietic cell transplantation (allo-HCT) has become a hope for a cure for many patients with high-risk hematologic malignancies. However, the high risks and…

Editor's Note: From June 12 to 15, 2025, the European Hematology Association (EHA) Annual Congress was held in Milan, Italy, bringing together top experts in the field of hematology from…

Editor's Note: At the 2025 European Hematology Association (EHA) Annual Congress, a dedicated guideline session was grandly held, bringing together top experts in the global hematology field. One of the…

Editor's Note: At the European Hematology Association (EHA) 2025 Annual Congress, the special session on Multiple Myeloma (MM) was filled to capacity. The core focus of the meeting was the…

Editor's Note: During the 2025 European Hematology Association (EHA) Annual Meeting, a session on the interpretation of the new Peripheral T-Cell Lymphoma (PTCL) guidelines drew significant attention. At this session,…

Editor's Note: In 2025, the highly anticipated 30th European Hematology Association (EHA) Annual Congress was grandly held in Milan, Italy. This conference brought together top experts and scholars from around…

Editor's Note: In 2025, the highly anticipated 30th European Hematology Association (EHA) Annual Meeting was grandly held in Milan, Italy in a combination of online and offline formats. Professor Johanna…

Editor's Note: At the recent European Hematology Association (EHA) Annual Congress, a premier event held in Milan, Italy, top global experts in hematology convened to discuss cutting-edge diagnostic and therapeutic…